HINJ Board of Trustees and Associate Members
HINJ BOARD OF TRUSTEES OFFICERS
Yin C. Becker – Chair
Vice President, Communications and Public Affairs
Mark J. Alles – Vice Chair
Chief Executive Officer
Donald W. Bohn – Vice Chair
Vice President, U.S. Government Affairs
Johnson & Johnson
Craig B. Bleifer – Treasurer and Immediate Past Chair
Senior Vice President, General Counsel and Secretary
Daiichi Sankyo, Inc.
Lisa M. Goldman – Board Secretary
Chief Communications Officer
Steven Immergut, M.P.H.
Vice President & Head of Communications and Advocacy Relations, Pharmaceutical
Executive Vice President and Chief Regulatory Officer
C. R. Bard, Inc.
Timothy M. Ring
Chairman and Chief Executive Officer
Executive Vice President and President, Hospital Therapies
Merck & Co., Inc.
Terri J. Lee
Vice President, Government Affairs and Policy
Novartis Pharmaceuticals Corporation
Daniel P. Casserly
U.S. Country Head
Government Affairs, Novartis Services, Inc.
Novo Nordisk, Inc.
Senior Director, Value Communication & Contract Strategy
BioPharm Franchise & Trade
Market Access Strategy & Innovation
HINJ ASSOCIATE MEMBER REPRESENTATIVES
Abbott Point of Care, Inc.
Amicus Therapeutics, Inc.
Jayne C. Gershkowit
Chief Patient Advocate
Eli Lilly and Company
Timothy P. Lyden
Director, State Government Affairs
Emisphere Technologies, Inc.
Alan L. Rubino
Chief Executive Officer and President
Michael R. Garone
Vice President, Finance and Chief Financial Officer
LEO Pharma A/S
Director, U.S. Government Affairs, U.S. Market Access and Public Affairs